Addition of apatinib to transarterial chemoembolization leads to improved outcome in patients with intermediate and advanced hepatocellular cancer

Added 247 days ago (18.01.2021)
Authors: Pauline Viviane Pochachristine.pocha@usd.edu; Chencheng Xiechristine.pocha@usd.edu; Christine Pochachristine.pocha@avera.org
Read article